Company Renalytix Plc Deutsche Boerse AG
Equities
2O9
GB00BYWL4Y04
Advanced Medical Equipment & Technology
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.114 EUR | -0.87% |
|
-0.87% | -39.04% |
Jun. 28 | ADRs Advance; Connect Biopharma Holdings Climbs 19% | DJ |
Jun. 28 | EARNINGS AND TRADING: Thruvision loss widens but Polarean loss narrows | AN |
Business Summary
Number of employees: 102
Sales per Business
GBP in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Artificial Intelligence-enabled in Vitro Diagnostics
100.0
%
| 2 | 100.0 % | 3 | 100.0 % | +26.61% |
Sales per region
GBP in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
United Kingdom
100.0
%
| 2 | 100.0 % | 3 | 100.0 % | +26.61% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
James McCullough
FOU | Founder | 56 | 18-03-14 |
Howard Doran
PSD | President | 63 | 23-08-31 |
Fergus Fleming
CTO | Chief Tech/Sci/R&D Officer | 57 | 18-03-14 |
Michael Donovan
CTO | Chief Tech/Sci/R&D Officer | 70 | 18-03-14 |
Joseph Hutson
PRN | Corporate Officer/Principal | - | 21-07-21 |
Sales & Marketing | - | 21-06-06 | |
Salim Hamir
SEC | Corporate Secretary | - | 18-05-31 |
Jed Fulk
SAM | Sales & Marketing | 64 | 21-10-06 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Daniel Levangie
BRD | Director/Board Member | 73 | 21-08-29 |
Chairman | 72 | 18-03-14 | |
James McCullough
FOU | Founder | 56 | 18-03-14 |
Fergus Fleming
CTO | Chief Tech/Sci/R&D Officer | 57 | 18-03-14 |
Erik Lium
BRD | Director/Board Member | 56 | 18-09-30 |
Catherine Coste
BRD | Director/Board Member | 58 | 23-06-29 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 154,368,191 | 94,996,551 ( 61.54 %) | 0 | 61.54 % |
Company contact information
![address Renalytix Plc(2O9)](https://cdn.zonebourse.com/static/address/109048399.png)
Sector
![Consensus](/images/consensus_flch.gif)
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-30.73% | 15.32B | |
-57.92% | 2.08B | |
+20.62% | 1.9B | |
-26.04% | 1.23B | |
+22.66% | 1.21B | |
+1.55% | 777M | |
-37.53% | 717M | |
-39.55% | 689M | |
-29.95% | 587M |
- Stock Market
- Equities
- RENX Stock
- 2O9 Stock
- Company Renalytix Plc